NBY

Novabay制药
AMEX

实时行情|Nasdaq Last Sale

1.010
+0.054
+5.65%
盘后: 0.9900 -0.02 -1.98% 18:58 08/13 EDT
开盘
0.9500
昨收
0.9560
最高
1.040
最低
0.9250
成交量
155.62万
成交额
--
52周最高
1.940
52周最低
0.2400
市值
4,215.73万
市盈率(TTM)
-3.0606
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测NBY价格均价为2.500,最高价位3.250,最低价为1.750。

EPS

NBY 新闻

更多
NovaBay Pharmaceuticals, Inc. (NBY) CEO Justin Hall on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 4天前
Earnings-related names dominate premarket losers
Seeking Alpha - Article · 6天前
Earnings movers dominate premarket losers list
Seeking Alpha - Article · 6天前
NovaBay EPS misses by $0.09, beats on revenue
NovaBay (NYSEMKT:NBY): Q2 GAAP EPS of -$0.15 misses by $0.09. Revenue of $3.98M (+122.3% Y/Y) beats by $0.98M. Shares -3.7%. Press Release
seekingalpha · 08/07 01:25
NovaBay Pharmaceuticals Reports Second Quarter 2020 Financial Results
Business Wire · 08/06 21:05
NovaBay Pharmaceuticals to Hold Second Quarter 2020 Conference Call on August 6
Business Wire · 07/27 11:50
OPK, NBEV, DVAX and ACAD among midday movers
Seeking Alpha - Article · 07/21 16:39
55 Biggest Movers From Yesterday
Gainers Perceptron, Inc. (NASDAQ: PRCP) shares jumped 107% to close at $6.50 on Tuesday after the company received an order from an automotive supplier for its in-line measurement technology.
Benzinga · 07/15 08:49

所属板块

生物技术和医学研究
+0.99%
制药与医学研究
-0.06%

热门股票

代码
价格
涨跌幅

NBY 简况

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which develops products for the eye care market. The Company focuses on commercializing prescription Avenova for managing hygiene of the eyelids and lashes in the United States. Avenova is an eye care product formulated with a form of hypochlorous acid called Neutrox. Its Avenova with Neutrox removes debris from the skin on the eyelids and lashes without burning or stinging. It develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. Its Aganocide compounds, led by auriclosene (NVC-422), are synthetic molecules with activity against bacteria, viruses and fungi. The Company's dermatology product includes CelleRx, a cleansing solution for post laser resurfacing, chemical peels and other cosmetic surgery procedures. Its wound care business includes the business of NeutroPhase product.
展开

微牛提供NovaBay Pharmaceuticals, Inc.(AMEX-NBY)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的NBY股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易NBY股票基本功能。